Meeting ReportOncology, Basic Science Track
64Cu-ATSM internal radiotherapy to treat colon cancer acquiring resistance to antiangiogenic therapy with bevacizumab
Yukie Yoshii, Takako Furukawa, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Ming-Rong Zhang, Masayuki Inubushi, Yasuhisa Fujibayashi and Tsuneo Saga
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 471;
Yukie Yoshii
3Molecular Imaging Center National Institute of Radiological Sciences Chiba Japan
Takako Furukawa
3Molecular Imaging Center National Institute of Radiological Sciences Chiba Japan
Mitsuyoshi Yoshimoto
2Division of Functional Imaging National Cancer Center Hospital East Chiba Japan
Hiroki Matsumoto
4Research Centre Nihon Medi-Physics Co., Ltd. Chiba Japan
Ming-Rong Zhang
3Molecular Imaging Center National Institute of Radiological Sciences Chiba Japan
Masayuki Inubushi
1Department of Nuclear Medicine Kawasaki Medical School Kurashiki Japan
Yasuhisa Fujibayashi
3Molecular Imaging Center National Institute of Radiological Sciences Chiba Japan
Tsuneo Saga
3Molecular Imaging Center National Institute of Radiological Sciences Chiba Japan
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
64Cu-ATSM internal radiotherapy to treat colon cancer acquiring resistance to antiangiogenic therapy with bevacizumab
Yukie Yoshii, Takako Furukawa, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Ming-Rong Zhang, Masayuki Inubushi, Yasuhisa Fujibayashi, Tsuneo Saga
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 471;
64Cu-ATSM internal radiotherapy to treat colon cancer acquiring resistance to antiangiogenic therapy with bevacizumab
Yukie Yoshii, Takako Furukawa, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Ming-Rong Zhang, Masayuki Inubushi, Yasuhisa Fujibayashi, Tsuneo Saga
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 471;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.